You searched for "macula"
50 Studies Every Ophthalmologist Should Know
1 February 2022
| Nixon Yang
|
EYE - General
This book features a compilation of 50 important clinical studies that have left a profound impact on the current clinical practice of ophthalmology. From the 1980 botulinum toxin injection study by AB Scott to the United Kingdom Glaucoma Treatment Study...
Sickle cell maculopathy
1 October 2021
| Sofia Rokerya
|
EYE - Vitreo-Retinal
|
OCT imaging, Sickle cell disease, Sickle cell maculopathy, Visual impairment
This paper reports the result of a prospective study to analyse the prevalence of sickle cell maculopathy (SCM) and its associations with age, sex, genotype, proliferative sickle cell retinopathy (PSR) stage, and the impact on visual acuity (VA). This study...
Intravitreal Bevacizumab for the prevention of postoperative proliferative vitreoretinopathy in high-risk patients
3 April 2024
| Sofia Rokerya
|
EYE - Vitreo-Retinal
This single- centre observational retrospective study was conducted to evaluate the effect of intravitreal injection of bevacizumab at the time surgery for rhegmatogenous retinal detachment (RRD) repair on postoperative proliferative vitreoretinopathy (PVR) in patients at high risk selected by laser...
Topcon Healthcare Lecture: Use of Macular Ganglion Cell Layer in Neuroophthalmology
19 March 2025
Speaker: Shveta BansalConsultant Ophthalmologist, Lancashire Eye Centre Shveta Bansal specialises in Neuroophthalmology and Ocular Motility. She offers specialist units in Neuro and Motility to the region and is a core partner in the Trust Neurosciences MDT. Her training included fellowships...
Vision loss during Eylea treatment for AMD
1 December 2017
| Saruban Pasu
|
EYE - Vitreo-Retinal
This report investigated patients who lost more than two lines of vision despite periodic injections of aflibercept and explored the factors associated with vision loss. One hundred and ninety-six eyes were included in this study over a two year period....
Aflibercept, bevacizumab or ranibizumab for diabetic macular oedema
1 April 2015
| Jonathan CP Roos
|
EYE - Vitreo-Retinal
Macular oedema (MO) is a leading cause of visual impairment in patients with diabetic retinopathy. Whilst laser photocoagulation therapy has been the proven treatment for decades, studies over the last five years have also established a role for anti-VEGF agents...
Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of CMO after phacoemulsification
This is a prospective randomised clinical trial study including patients older than 40 years with age related cataract and normal ophthalmic examination. The patients are randomised into three different groups and the objective of the study is to compare the...Atrophy and anti-VEGF
1 August 2019
| Saruban Pasu
|
EYE - Vitreo-Retinal
The aim of this study was to investigate treatment factors, along with ocular and systemic factors for their association with macular atrophy (MA) incidence in eyes with neovascular age-related macular degeneration (nAMD) treated with anti-VEGF aflibercept or ranibizumab according to...
Subthreshold micropulse laser in BRVO
1 August 2019
| Saruban Pasu
|
EYE - Vitreo-Retinal
The purpose of this retrospective, consecutive, single-centre, non-randomised, and case-control study was to verify the therapeutic effects and safety of oedema (from branch retinal vein occlusion (BRVO)) recurrence suppression effect using 577-nm subthreshold micropulse laser photocoagulation (SMLP) in combination with...
Transient macular thinning with Densiron 68
4 August 2021
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
|
OCT, Retinal detachment, heavy silicone oil, macula
Densiron 68 is a heavy silicone oil (HSO) used to treat rhegmatogenous retinal detachments (RRD) with inferior retinal breaks. The authors compared changes in retinal thickness during and after the use of Densiron endotamponade, and looked at any association between...
ILM peeling techniques in myopic traction maculopathy
29 November 2024
| Kurt Spiteri Cornish
|
EYE - Vitreo-Retinal
Myopic traction maculopathy (MTM) is a sight-threatening complication of high myopia including macular retinoschisis (MRS) or foveoschisis, foveal detachment (FD) and myopic macular hole (MMH). Standard surgical treatment is vitrectomy with internal limiting membrane (ILM) peeling, but full-thickness macular hole...
Part 2: the Arclight Device: frugal imaging for eyecare
3 June 2024
| Andrew Blaikie, Sahib Tuteja, Gatera Fiston Kitema
|
EYE - General
In this three-part series (Click here for Part 1 and here for Part 3) Andrew Blaikie and his team explore the role and application of the Arclight Device in Imaging of the Eye. There are many different types of ophthalmic...